Ken Johnson
Chief Tech/Sci/R&D Officer chez XERIS BIOPHARMA HOLDINGS, INC.
Fortune : 987 561 $ au 31/03/2024
Postes actifs de Ken Johnson
Sociétés | Poste | Début | Fin |
---|---|---|---|
XERIS BIOPHARMA HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01/10/2021 | - |
Historique de carrière de Ken Johnson
Anciens postes connus de Ken Johnson
Sociétés | Poste | Début | Fin |
---|---|---|---|
MERCK & CO., INC. | Chief Tech/Sci/R&D Officer | 01/03/2016 | 01/01/2017 |
Circassia Pharmaceuticals, Inc.
Circassia Pharmaceuticals, Inc. Medical DistributorsDistribution Services Part of Niox Group Plc, Circassia Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development and commercialization of respiratory products. Circassia Pharmaceuticals is based in Raleigh, NC. The private company's main product, tudorza® pressair®, is an anticholinergic medication used for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). | Chief Tech/Sci/R&D Officer | 01/01/2015 | 01/01/2016 |
DURATA THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 01/04/2012 | 01/03/2015 |
Caremark Rx, Inc.
Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Caremark Rx, Inc. provides pharmaceutical and prescription benefit program services. The company primarily sponsors of health benefit plans and individuals located throughout the United States. The company was established in 1993 and is headquartered in Nashville, TN. | Corporate Officer/Principal | 01/01/2000 | 01/01/2002 |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Chief Tech/Sci/R&D Officer | 05/08/2010 | - |
Caremark LLC | Chief Tech/Sci/R&D Officer | - | - |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Chief Tech/Sci/R&D Officer | 01/03/2017 | - |
General Counsel | 01/03/2017 | - |
Formation de Ken Johnson
University of Minnesota | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 10 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 7 |
Corporate Officer/Principal | 1 |
General Counsel | 1 |
Sectorielle
Health Technology | 6 |
Health Services | 2 |
Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
MERCK & CO., INC. | Health Technology |
XERIS BIOPHARMA HOLDINGS, INC. | Health Technology |
Entreprise privées | 6 |
---|---|
Caremark Rx, Inc.
Caremark Rx, Inc. Medical/Nursing ServicesHealth Services Caremark Rx, Inc. provides pharmaceutical and prescription benefit program services. The company primarily sponsors of health benefit plans and individuals located throughout the United States. The company was established in 1993 and is headquartered in Nashville, TN. | Health Services |
Xeris Pharmaceuticals, Inc.
Xeris Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Xeris Pharmaceuticals, Inc. operates as a pharmaceutical company. It develops and commercializes ready-to-use, liquid-stable injectables. The firm offers XeriSol and XeriJect formulation technologies. Its products include Gvoke Pre-Filled Syringe and Gvoke HypoPen. The company was founded by Steven Prestrelski and John Kinzell in 2005 and is headquartered in Chicago, IL. | Health Technology |
Caremark LLC | |
Horizon Pharma, Inc.
Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL. | Health Technology |
Circassia Pharmaceuticals, Inc.
Circassia Pharmaceuticals, Inc. Medical DistributorsDistribution Services Part of Niox Group Plc, Circassia Pharmaceuticals, Inc. is a pharmaceutical company that specializes in the development and commercialization of respiratory products. Circassia Pharmaceuticals is based in Raleigh, NC. The private company's main product, tudorza® pressair®, is an anticholinergic medication used for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). | Distribution Services |
Durata Therapeutics, Inc.
Durata Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Durata Therapeutics, Inc. develops and commercializes novel therapeutics for infectious diseases and acute illnesses. The company was founded on November 4, 2009 and is headquartered in Chicago, IL. | Health Technology |
- Bourse
- Insiders
- Ken Johnson
- Expérience